Comprehensive molecular phenotyping of ARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities. - Xu C; Huang KK; Law JH; Chua JS; Sheng T; Flores NM; Pizzi MP; Okabe A; Tan ALK; Zhu F; Kumar V; Lu X; et al. (Gut, 2023)